Pablo Stringa
Overview
Explore the profile of Pablo Stringa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papa-Gobbi R, Stringa P, Gentilini M, Ivanoff I, Machuca M, Arreola N, et al.
PLoS One
. 2025 Jan;
20(1):e0307534.
PMID: 39854413
Background: Intestinal transplantation (ITx) represents the only curative option for patients with irreversible intestinal failure. Nevertheless, its rejection rate surpasses that of other solid organ transplants due to the heightened...
2.
Abate J, Marinoff I, Arnal N, Machuca M, Papa-Gobbi R, Vecchio L, et al.
Acta Cir Bras
. 2025 Jan;
40():e400225.
PMID: 39775489
Purpose: To mitigate ischemia-reperfusion injury (IRI) triggered in solid organ transplant procedures, we aimed to evaluate the effects of multi-organ abdominal ischemic preconditioning (MAIP) in the context of renal IRI....
3.
Moreira J, Stringa P, Gentilini M, Arriola C, Ivanoff I, Rumbo M, et al.
J Gastrointest Surg
. 2024 Apr;
28(7):1169-1171.
PMID: 38636722
No abstract available.
4.
Zhang T, Wahib R, Zazara D, Lucke J, Shiri A, Kempski J, et al.
Oncoimmunology
. 2023 Oct;
12(1):2269634.
PMID: 37876835
Metastasis is a cancer-related systemic disease and is responsible for the greatest mortality rate among cancer patients. Interestingly, the interaction between the immune system and cancer cells seems to play...
5.
Serradilla J, Andres Moreno A, Talayero P, Burgos P, Machuca M, Camps Ortega O, et al.
Transpl Int
. 2023 Sep;
36:11518.
PMID: 37745640
Considering recent clinical and experimental evidence, expectations for using DCD-derived intestines have increased considerably. However, more knowledge about DCD procedure and long-term results after intestinal transplantation (ITx) is needed. We...
6.
Giannou A, Kempski J, Zhang T, Lucke J, Shiri A, Zazara D, et al.
Front Oncol
. 2023 Jun;
13:1170502.
PMID: 37324022
Background: The immune system plays a pivotal role in cancer progression. Interleukin 22 binding protein (IL-22BP), a natural antagonist of the cytokine interleukin 22 (IL-22) has been shown to control...
7.
Abate J, Lausada N, Vecchio Dezillio L, Moreira J, Marinoff I, Ferreyra Compagnucci M, et al.
Lab Anim
. 2023 Feb;
57(4):443-454.
PMID: 36748321
The use of animals to gain knowledge and understanding of diseases needs to be reduced and refined. In the field of intestinal research, because of the complexity of the gut...
8.
Andres A, Encinas J, Sanchez-Galan A, Rodriguez J, Estefania K, Sacristan R, et al.
Am J Transplant
. 2023 Feb;
23(4):577-581.
PMID: 36725427
The current shortage of pediatric multivisceral donors accounts for the long time and mortality on the waiting list of pediatric patients. The use of donors after cardiac death, especially after...
9.
Stringa P, Vecchio Dezillio L, Talayero P, Serradilla J, Errea A, Machuca M, et al.
Transpl Int
. 2023 Jan;
36:10803.
PMID: 36713114
There is an urgent need to address the shortage of potential multivisceral grafts in order to reduce the average time in waiting list. Since donation after circulatory death (DCD) has...
10.
Andres A, Talayero P, Alcolea Sanchez A, Sanchez Galan A, Rodriguez J, Bueno Jimenez A, et al.
Transpl Int
. 2021 Jun;
34(10):1895-1907.
PMID: 34174115
To review our experience using sirolimus in a single centre paediatric intestinal transplantation cohort. Intestinal transplant patients with more than 3 months follow-up were divided into two groups according to...